Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19
Background Several characteristics of the metabolic syndrome, such as obesity and hypertension, have emerged as risk factors for a poor clinical outcome in COVID-19. However, most reports lack data on the metabolic syndrome itself. This study investigated prospectively the relationship between respi...
Main Authors: | Manuel Castro Cabezas, Erwin Birnie, Cathelijne M van Zelst, Matthijs L Janssen, Nadine Pouw, Gert-Jan Braunstahl |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-05-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000792.full |
Similar Items
-
Systemic Inflammation and Lung Function Impairment in Morbidly Obese Subjects with the Metabolic Syndrome
by: Astrid van Huisstede, et al.
Published: (2013-01-01) -
Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
by: Matthew John Robinson, et al.
Published: (2020-07-01) -
Metabolic precursors of surfactant disaturated-phosphatidylcholine in preterms with respiratory distress
by: Paola E. Cogo, et al.
Published: (2009-11-01) -
Acute respiratory distress syndrome, metabolic acidosis, and respiratory acidosis associated with citalopram overdose
by: Hawa Edriss, et al.
Published: (2013-11-01) -
Pneumothorax in patients with prior or current COVID-19 pneumonia
by: Matthijs L. Janssen, et al.
Published: (2020-01-01)